408 related articles for article (PubMed ID: 28025863)
21. Cancer anorexia and cachexia.
Tisdale MJ
Nutrition; 2001 May; 17(5):438-42. PubMed ID: 11377146
[TBL] [Abstract][Full Text] [Related]
22. The role of the vagus nerve in mediating the long-term anorectic effects of leptin.
Sachot C; Rummel C; Bristow AF; Luheshi GN
J Neuroendocrinol; 2007 Apr; 19(4):250-61. PubMed ID: 17355316
[TBL] [Abstract][Full Text] [Related]
23. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome.
Plata-Salamán CR
Nutrition; 2000 Oct; 16(10):1009-12. PubMed ID: 11054608
[TBL] [Abstract][Full Text] [Related]
24. Targeting Obesity and Cachexia: Identification of the GFRAL Receptor-MIC-1/GDF15 Pathway.
Breit SN; Tsai VW; Brown DA
Trends Mol Med; 2017 Dec; 23(12):1065-1067. PubMed ID: 29129392
[TBL] [Abstract][Full Text] [Related]
25. MCG101-induced cancer anorexia-cachexia features altered expression of hypothalamic Nucb2 and Cartpt and increased plasma levels of cocaine- and amphetamine-regulated transcript peptides.
Burgos JR; Iresjö BM; Smedh U
Oncol Rep; 2016 Apr; 35(4):2425-30. PubMed ID: 26780979
[TBL] [Abstract][Full Text] [Related]
26. Metformin triggers a kidney GDF15-dependent area postrema axis to regulate food intake and body weight.
Zhang SY; Bruce K; Danaei Z; Li RJW; Barros DR; Kuah R; Lim YM; Mariani LH; Cherney DZ; Chiu JFM; Reich HN; Lam TKT
Cell Metab; 2023 May; 35(5):875-886.e5. PubMed ID: 37060902
[TBL] [Abstract][Full Text] [Related]
27. Anorexia/cachexia of chronic diseases: a role for the TGF-β family cytokine MIC-1/GDF15.
Tsai VW; Husaini Y; Manandhar R; Lee-Ng KK; Zhang HP; Harriott K; Jiang L; Lin S; Sainsbury A; Brown DA; Breit SN
J Cachexia Sarcopenia Muscle; 2012 Dec; 3(4):239-43. PubMed ID: 22936174
[TBL] [Abstract][Full Text] [Related]
28. Effects of spontaneous physical exercise on experimental cancer anorexia and cachexia.
Daneryd PL; Hafström LR; Karlberg IH
Eur J Cancer; 1990; 26(10):1083-8. PubMed ID: 1703420
[TBL] [Abstract][Full Text] [Related]
29. Hormonal, hypothalamic and striatal responses to reduced body weight gain are attenuated in anorectic rats bearing small tumors.
Pourtau L; Leemburg S; Roux P; Leste-Lasserre T; Costaglioli P; Garbay B; Drutel G; Konsman JP
Brain Behav Immun; 2011 May; 25(4):777-86. PubMed ID: 21334429
[TBL] [Abstract][Full Text] [Related]
30. Resistance exercise modulates lipid plasma profile and cytokine content in the adipose tissue of tumour-bearing rats.
Donatto FF; Neves RX; Rosa FO; Camargo RG; Ribeiro H; Matos-Neto EM; Seelaender M
Cytokine; 2013 Feb; 61(2):426-32. PubMed ID: 23178146
[TBL] [Abstract][Full Text] [Related]
31. Cytokines and cancer anorexia cachexia syndrome.
Bennani-Baiti N; Davis MP
Am J Hosp Palliat Care; 2008; 25(5):407-11. PubMed ID: 18403577
[TBL] [Abstract][Full Text] [Related]
32. [The incidence and pathogenesis of cancer anorexia-cachexia syndrome in lung cancer].
Kosacka M; Weryńska B; Gołecki M; Jankowska R; Passowicz-Muszyńska E
Pneumonol Alergol Pol; 2008; 76(5):360-5. PubMed ID: 19003767
[TBL] [Abstract][Full Text] [Related]
33. MyD88 signalling is critical in the development of pancreatic cancer cachexia.
Zhu X; Burfeind KG; Michaelis KA; Braun TP; Olson B; Pelz KR; Morgan TK; Marks DL
J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):378-390. PubMed ID: 30666818
[TBL] [Abstract][Full Text] [Related]
34. TGF-b superfamily cytokine MIC-1/GDF15 is a physiological appetite and body weight regulator.
Tsai VW; Macia L; Johnen H; Kuffner T; Manadhar R; Jørgensen SB; Lee-Ng KK; Zhang HP; Wu L; Marquis CP; Jiang L; Husaini Y; Lin S; Herzog H; Brown DA; Sainsbury A; Breit SN
PLoS One; 2013; 8(2):e55174. PubMed ID: 23468844
[TBL] [Abstract][Full Text] [Related]
35. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
[TBL] [Abstract][Full Text] [Related]
36. Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.
Zhang H; Garcia JM
Expert Opin Pharmacother; 2015 Jun; 16(8):1245-53. PubMed ID: 25945893
[TBL] [Abstract][Full Text] [Related]
37. Characterization of cachexia in the human fibrosarcoma HT-1080 mouse tumour model.
Bernardo B; Joaquim S; Garren J; Boucher M; Houle C; LaCarubba B; Qiao S; Wu Z; Esquejo RM; Peloquin M; Kim H; Breen DM
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1813-1829. PubMed ID: 32924335
[TBL] [Abstract][Full Text] [Related]
38. Skeletal muscle UCP2 and UCP3 gene expression in a rat cancer cachexia model.
Sanchís D; Busquets S; Alvarez B; Ricquier D; López-Soriano FJ; Argilés JM
FEBS Lett; 1998 Oct; 436(3):415-8. PubMed ID: 9801160
[TBL] [Abstract][Full Text] [Related]
39. Cachexia in cancer patients.
Tisdale MJ
Nat Rev Cancer; 2002 Nov; 2(11):862-71. PubMed ID: 12415256
[No Abstract] [Full Text] [Related]
40. Z-505 hydrochloride, an orally active ghrelin agonist, attenuates the progression of cancer cachexia via anabolic hormones in Colon 26 tumor-bearing mice.
Yoshimura M; Shiomi Y; Ohira Y; Takei M; Tanaka T
Eur J Pharmacol; 2017 Sep; 811():30-37. PubMed ID: 28529141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]